|
End-of-day quote
Shanghai S.E.
08/09/2026
|
5-day change | 1st Jan Change | ||
| 14.55 CNY | -0.48% |
|
-0.89% | -3.45% |
| 09-02 | CICC Starts Tasly Pharmaceutical Group at Outperform with 17.80 Yuan Price Target | MT |
| 08-24 | Tasly Pharmaceutical to Buy 4 Billion Yuan of Wealth Management Products | MT |
| Market Cap | 21.74B 3.24B 2.78B 2.62B 2.39B 4.46B 307B 4.48B 31.04B 12.01B 157B 12.16B 11.9B 499B | P/E 2026 * |
16.3x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 20.19B 3.01B 2.59B 2.43B 2.22B 4.14B 285B 4.17B 28.84B 11.16B 146B 11.3B 11.05B 464B | EV / Sales 2026 * |
2.34x | EV / Sales 2027 * | 1.71x |
| Free-Float |
47.11% | Yield 2026 * |
2.67% | Yield 2027 * | 3.24% |
| 1 day | -0.48% | ||
| 1 week | -0.89% | ||
| Current month | -0.89% | ||
| 1 month | -7.44% | ||
| 3 months | +2.54% | ||
| 6 months | +2.32% | ||
| Current year | -3.45% |
| 1 week | 14.46 |  | 14.92 |
| 1 month | 14.46 | | 15.97 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 16.53 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 07/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 08/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 30/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 01/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 09/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 07/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | -0.89% | -11.28% | +7.94% | 3.25B | |
| +0.59% | +0.95% | -14.22% | -3.84% | 13.44B | |
| +0.74% | +1.93% | -30.61% | -55.47% | 4.94B | |
| -0.83% | -1.51% | -4.68% | -3.76% | 4.49B | |
| +0.82% | -0.25% | -3.05% | -28.49% | 3.92B | |
| +0.37% | -1.17% | -22.41% | +5.76% | 3.53B | |
| +0.47% | -0.08% | +0.54% | +1.69% | 3.53B | |
| +0.20% | -0.54% | -22.38% | -14.12% | 2.33B | |
| +1.51% | +0.35% | -26.51% | -13.82% | 1.68B | |
| +2.06% | +0.45% | -0.45% | -10.98% | 1.65B | |
| Average | +0.54% | +0.57% | -13.50% | -11.51% | 4.28B | |
| Weighted average by Cap. | +0.44% | +0.60% | -13.71% | -11.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.63B 1.29B 1.11B 1.04B 950M 1.77B 122B 1.78B 12.33B 4.77B 62.33B 4.83B 4.72B 198B | 9.36B 1.39B 1.2B 1.13B 1.03B 1.92B 132B 1.93B 13.36B 5.17B 67.55B 5.23B 5.12B 215B |
| Net income | 1.34B 199M 171M 161M 147M 274M 18.89B 276M 1.91B 739M 9.65B 748M 732M 30.72B | 1.58B 235M 202M 190M 174M 324M 22.32B 326M 2.26B 873M 11.41B 884M 865M 36.31B |
| Net Debt | -1.54B -230M -198M -186M -170M -317M -21.81B -319M -2.2B -853M -11.15B -864M -845M -35.47B | -5.71B -851M -732M -688M -628M -1.17B -80.69B -1.18B -8.16B -3.16B -41.24B -3.2B -3.13B -131B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/09/26 | CN¥14.55 | -0.48% | 10,011,300 |
| 07/09/26 | CN¥14.62 | -0.75% | 11,047,854 |
| 04/09/26 | CN¥14.73 | +0.34% | 10,194,160 |
| 03/09/26 | CN¥14.68 | +0.34% | 10,072,372 |
| 02/09/26 | CN¥14.63 | -0.88% | 10,324,170 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
